Trials / Unknown
UnknownNCT04823962
Effect of rhGM-CSF on the Healing of Venous Leg Ulcers
Effect of Topical rhGM-CSF on the Healing of Venous Leg Ulcers: a Randomized, Placebo-controlled, Double-blind, Clinical Phase II Study
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Reponex Pharmaceuticals A/S · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to examine whether local administration of the growth factor rhGM-CSF incorporated into a hydrogel, can accelerate wound healing when applied to venous leg ulcers, and whether this is safe.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | rhGM-CSF + hydrogel | The active substance: molgramostim (rhGM-CSF) |
| DRUG | Placebo hydrogel | Placebo hydrogel |
| OTHER | Standard care | Compression therapy and neutral dressings |
Timeline
- Start date
- 2021-03-11
- Primary completion
- 2023-12-30
- Completion
- 2023-12-30
- First posted
- 2021-04-01
- Last updated
- 2022-11-17
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04823962. Inclusion in this directory is not an endorsement.